April 2026
1. GRACE M, Beeravolu H, Alhamshari A, Skelin J, et al
   Characterization of patient-derived HPV16 E6 and E7 variant alleles.
   J Virol. 2026;100:e0023626.
   

   >> Share

   
   
2. TREJO-CERRO O, Bergant Marusic M, Wlodarczyk P, Repnik U, et al
   Regulation of HPV-16 infection by ubiquitination of the L1 major capsid protein.
   J Virol. 2026 Apr 13:e0028526. doi: 10.1128/jvi.00285.
   

   >> Share

   
   November 2025
3. COX JB, Murphy EA
   Protein-S-nitrosylation of adenovirus-5 E1A and human papillomavirus 16 E7 limits their ability to inhibit STING activity.
   J Virol. 2025;99:e0145625.
   

   >> Share

   
   October 2025
4. DUXBURY KR, Zhang L, Muelhbauer LK, Hayes M, et al
   MmuPV1 E7 promotes phenotypes associated with "high-risk" HPV infection in mouse keratinocytes.
   J Virol. 2025 Oct 30:e0109725. doi: 10.1128/jvi.01097.
   

   >> Share

   
   September 2025
5. RENNER J, Boldt K, Wieland A, Grundhoff A, et al
   Activation of the HPV16 late promoter by viral E2 and cellular BRD4 and ZC3H4 proteins.
   J Virol. 2025;99:e0076225.
   

   >> Share

   
   August 2025
6. BILLINGSLEY CL, Doud EH, Smith-Kinnaman W, Mosley AL, et al
   Proliferative proteome induced by HPV 16E6 and NFX1-123 partnership in longitudinal keratinocyte cultures.
   J Virol. 2025 Aug 13:e0096725. doi: 10.1128/jvi.00967.
   

   >> Share

   
   July 2025
7. IBRAGIMOV R, Babok S, Lototskaja-Perepelenko E, Ivanova L, et al
   Targeting papillomavirus infections: high-throughput screening reveals an effective inhibitor of cutaneous beta-HPV types.
   J Virol. 2025 Jul 8:e0091825. doi: 10.1128/jvi.00918.
   

   >> Share

   
   March 2025
8. GBALA I, Kavcic N, Banks L
   The retinoblastoma protein contributes to maintaining the stability of HPV E7 in cervical cancer cells.
   J Virol. 2025 Mar 25:e0220324. doi: 10.1128/jvi.02203.
   

   >> Share

   
   January 2025
9. KEIFFER TR, DiGiuseppe S, Guion L, Bienkowska-Haba M, et al
   HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis.
   J Virol. 2025;99:e0093724.
   

   >> Share

   
   October 2024
10. SCHAAL DL, Amucheazi AA, Jones SC, Nkadi EH, et al
    Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors.
    J Virol. 2024;98:e0099524.
    

    >> Share

    
    
11. JONSSON J, Zhai Q, Schwartz S, Kajitani N, et al
    hnRNP H controls alternative splicing of human papillomavirus type 16 E1, E6, E7, and E6;E7 mRNAs via GGG motifs.
    J Virol. 2024;98:e0095124.
    

    >> Share

    
    
12. JAMES CD, Lewis RL, Fakunmoju AL, Witt AJ, et al
    Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses.
    J Virol. 2024;98:e0102424.
    

    >> Share

    
    
13. PENG Y, Wang W, Liu X, Li S, et al
    Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.
    J Virol. 2024;98:e0067724.
    

    >> Share

    
    September 2024
14. JAMES CD, Youssef A, Prabhakar AT, Otoa R, et al
    Human papillomavirus 16 replication converts SAMHD1 into a homologous recombination factor and promotes its recruitment to replicating viral DNA.
    J Virol. 2024;98:e0082624.
    

    >> Share

    
    July 2024
15. JOSE L, Smith K, Crowner A, Androphy EJ, et al
    Senataxin mediates R-loop resolution on HPV episomes.
    J Virol. 2024 Jul 24:e0100324. doi: 10.1128/jvi.01003.
    

    >> Share

    
    June 2024
16. BRONIARCZYK J, Trejo-Cerro O, Massimi P, Kavcic N, et al
    HPV-18 E6 enhances the interaction between EMILIN2 and SNX27 to promote WNT signaling.
    J Virol. 2024 Jun 14:e0073524. doi: 10.1128/jvi.00735.
    

    >> Share

    
    May 2024
17. CHEN L, Hu H, Pan Y, Lu Y, et al
    The role of HPV11 E7 in modulating STING-dependent interferon beta response in recurrent respiratory papillomatosis.
    J Virol. 2024;98:e0192523.
    

    >> Share

    
    April 2024
18. QUADIRI A, Prakash S, Dhanushkodi NR, Singer M, et al
    Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4(+) and CD8(+) T cells and protects against recurrent
    J Virol. 2024 Apr 8:e0159623. doi: 10.1128/jvi.01596.
    

    >> Share

    
    February 2024
19. KHALIL MI, Yang C, Vu L, Chadha S, et al
    The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    J Virol. 2024;98:e0172623.
    

    >> Share

    
    October 2023
20. PRABHAKAR AT, James CD, Fontan CT, Otoa R, et al
    Direct interaction with the BRD4 carboxyl-terminal motif (CTM) and TopBP1 is required for human papillomavirus 16 E2 association with mitotic chromatin and plasmid segregation function.
    J Virol. 2023;97:e0078223.
    

    >> Share

    
    September 2023
21. BOURNE N, Keith CA, Miller AL, Pyles RB, et al
    Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease.
    J Virol. 2023;97:e0066923.
    

    >> Share

    
    August 2023
22. MORI S, Ishii Y, Takeuchi T, Kukimoto I, et al
    Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
    J Virol. 2023;97:e0081523.
    

    >> Share

    
    June 2023
23. ZWOLINSKA K, Bienkowska-Haba M, Scott RS, Keiffer T, et al
    Experimental Support for Human Papillomavirus Genome Amplification Early after Infectious Delivery.
    J Virol. 2023;97:e0021423.
    

    >> Share

    
    
24. LOTOTSKAJA E, Liblekas L, Piirsoo M, Laanevali A, et al
    Phosphorylation of E2 Serine Residue 402 Is Required for the Transcription and Replication of the HPV5 Genome.
    J Virol. 2023;97:e0064323.
    

    >> Share

    
    May 2023
25. ISHII Y, Yamaji T, Sekizuka T, Homma Y, et al
    Folliculin Prevents Lysosomal Degradation of Human Papillomavirus To Support Infectious Cell Entry.
    J Virol. 2023;97:e0005623.
    

    >> Share

    
    March 2023
26. PRABHAKAR AT, James CD, Fontan CT, Otoa R, et al
    Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle.
    J Virol. 2023;97:e0006323.
    

    >> Share

    
    
27. CHEN J, Wang D, Wang Z, Wu K, et al
    Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    J Virol. 2023;97:e0181922.
    

    >> Share

    
    February 2023
28. BIENKOWSKA-HABA M, Zwolinska K, Keiffer T, Scott RS, et al
    Human Papillomavirus Genome Copy Number Is Maintained by S-Phase Amplification, Genome Loss to the Cytosol during Mitosis, and Degradation in G(1) Phase.
    J Virol. 2023;97:e0187922.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share